申请人:Medshine Discovery Inc.
公开号:US11155523B2
公开(公告)日:2021-10-26
Provided is a CCR2/CCR5 receptor antagonist and the use thereof in the preparation of a drug for treating diseases associated with the CCR2/CCR5. In particular, disclosed are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.
本发明提供了一种 CCR2/CCR5 受体拮抗剂及其在制备治疗与 CCR2/CCR5 相关疾病的药物中的用途。特别是公开了由式(I)代表的化合物及其药学上可接受的盐。